![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Hong Kong Firm Draws Warning for Testing, Labeling Deficiencies
Hong Kong Firm Draws Warning for Testing, Labeling Deficiencies
March 12, 2018
The FDA issued Nan San Pharmaceutical a warning letter for significant violations of CGMPs, including a failure to test product batches and inadequately labeling of product expiration dates.
During a September inspection at the firm’s Hong Kong facility, the inspector noted that the firm did not test all batches of over-the-counter topical liquid analgesics before batch release.
The firm performed microbial test limits for only one batch of its Easy-Flex analgesic lotion between 2013 and 2016, but reported the same results in order to release later batches to the U.S., the agency said.
Upcoming Events
-
21Oct